Olanzapine Instant Eg

Olanzapine, the active ingredient in Olanzapine Instant Eg, is an atypical antipsychotic presented as a strength/form for oral use. It treats schizophrenia and bipolar I disorder in adults and adolescents. GNH USA supplies Olanzapine Instant Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Olanzapine Instant Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Olanzapine is an atypical antipsychotic that modulates neurotransmitter activity in psychotic and mood disorders.

- Schizophrenia: Reduces positive and negative symptoms and helps prevent relapse. - Bipolar I disorder (manic phase): Controls acute manic episodes and stabilises mood. - Schizoaffective disorder: Alleviates both psychotic and mood components of the condition. - Maintenance therapy: Supports long‑term symptom control in chronic psychotic disorders.

Olanzapine may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Weight gain - Sedation - Dry mouth - Constipation - Increased appetite - Dizziness

Serious or Rare Side Effects: - Neuroleptic malignant syndrome - Tardive dyskinesia - Severe hyperglycaemia - Agranulocytosis - Seizures - Elevated prolactin levels

Olanzate   

-     a  a  t  t  t  t  d  t  g  g  t -   t  t -  f  t -  d  t -  a  ewline -  ewline   ewline -  ewline   d  -  ewline -  ewline - ",